Clinical Trials

90 studies in Hematology in Minnesota

  1. A 3-Arm Randomized Phase II Trial of Bendamustine-Rituximab (BR) Followed by Rituximab vs Bortezomib-BR (BVR) Followed by Rituximab vs BR Followed by Lenalidomide/Rituximab in High Risk Follicular Lymphoma
    1. Minnesota
  2. Consortium for the Sharing of Germ Line DNA and Tissue From Subjects With Mesothelioma
    1. Minnesota
  3. Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
    1. Minnesota
  4. A Phase II-R and a Phase III Trial Evaluating Both *Erlotinib (PH II-R) and Chemoradiation (PH III) as Adjuvant Treatment For Patients With Resected Head of Pancreas Adenocarcinoma
    1. Minnesota
  5. Biospecimen Resource for Familial Pancreas Research, a Data and Tissue Registry (Also Known as a Bio-repository, Bio-bank, Data and Tissue Database, Data and Tissue Bank, Etc.) to Help Advance Research in Familial Pancreas Disease
    1. Minnesota
  6. A Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients With a High Risk of Recurrence
    1. Minnesota
  7. Treatment of Children With All Stages of Hepatoblastoma
    1. Minnesota
  8. Phase I Study of Z-Endoxifen as a Hormonal Therapy for Breast Cancer
    1. Arizona,
    2. Minnesota
  9. A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared With Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease
    1. Minnesota
  10. A Phase III Trial Evaluating The Addition Of Trastuzumab To Trimodality Treatment Of Her2-Overexpressing Esophageal Adenocarcinoma
    1. Arizona,
    2. Minnesota
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. Next